Your browser doesn't support javascript.
loading
A modular PROTAC design for target destruction using a degradation signal based on a single amino acid.
Shanmugasundaram, Karthigayan; Shao, Peng; Chen, Han; Campos, Bismarck; McHardy, Stanton F; Luo, Tuoping; Rao, Hai.
  • Shanmugasundaram K; Department of Molecular Medicine, University of Texas Health, San Antonio, Texas 78229.
  • Shao P; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
  • Chen H; Key Laboratory of Bioorganic Chemistry and Molecular Engineering, Ministry of Education and Beijing National Laboratory for Molecular Science, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
  • Campos B; Center for Innovative Drug Discovery, University of Texas, San Antonio, Texas 78249.
  • McHardy SF; Center for Innovative Drug Discovery, University of Texas, San Antonio, Texas 78249.
  • Luo T; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
  • Rao H; Key Laboratory of Bioorganic Chemistry and Molecular Engineering, Ministry of Education and Beijing National Laboratory for Molecular Science, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
J Biol Chem ; 294(41): 15172-15175, 2019 10 11.
Article en En | MEDLINE | ID: mdl-31511327
ABSTRACT
Proteolysis targeting chimeras (PROTACs) are bivalent molecules that bring a cellular protein to a ubiquitin ligase E3 for ubiquitination and subsequent degradation. Although PROTAC has emerged as a promising therapeutic means for cancers as it rewires the ubiquitin pathway to destroy key cancer regulators, the degradation signals/pathways for PROTACs remain underdeveloped. Here we append single amino acids, the simplest degradation signal, to a ligand specific for estrogen-related receptor α (ERRα) and demonstrate their utility in ERRα knockdown via the N-end rule pathway and also their efficiency in the growth inhibition of breast cancer cells. The modular design described offers unique advantages including smaller molecular size with shortest degradation sequences and degradation speed modulation with different amino acids. Our study expands the repertoire of limited ubiquitin pathways currently available for PROTACs and could be easily adapted for broad use in targeted protein degradation.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Bibliotecas de Moléculas Pequeñas / Proteolisis Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Bibliotecas de Moléculas Pequeñas / Proteolisis Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article